The largest database of trusted experimental protocols

6 protocols using isotonic saline

1

Renal and Cardiovascular Responses to Saline Infusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Renal hemodynamic, urinary excretion and cardiovascular (MAP and heart rate) responses to 180 min of isotonic saline (0.9% sodium chloride, 154 mmol/l, Baxter Healthcare, USA) were examined on a separate day. Similar to the time-control series, following a 1-h equilibration period, cardiovascular and renal function were measured over 60 min to establish baseline before commencement of isotonic saline infusion at 0.13 ml/kg/min equating to 20 µmol Na+/kg/min for 180 min (i.v) followed by a 180 min period of recovery, with blood and urine samples collected as described above. A 5 ml blood sample was also collected at end of baseline, saline infusion and recovery period for analysis of plasma renin activity (PRA) via radio-immunoassay (ProSearch International). Urine samples were analyzed for sodium concentration (Beckman Coulter, Monash Medical Centre) and sodium excretion calculated.
+ Open protocol
+ Expand
2

Cardiovascular, Kidney Responses to Saline

Check if the same lab product or an alternative is used in the 5 most similar protocols
On a separate day, the cardiovascular, kidney hemodynamic and excretory responses to isotonic saline infusion (0.9% sodium chloride, 154 mmol/l, Baxter Healthcare, U.S.A.) for 180 min was examined. Following one hour of equilibration, urine samples were collected every 20 min throughout the study with an arterial blood sample (3 ml) taken at mid-point of each urine collection. Baseline data were collected over a period of 60 min. Then isotonic saline infusion was commenced at 0.13 ml/kg/min, which equates to 20 µmol Na+/kg/min [27 (link)], for 180 min (i.v) followed by a 180-min period of recovery. During this period both BP (systolic, diastolic and MAP) and HR were measured continuously. In addition, arterial blood samples (5 ml) were collected on EDTA at the end of the baseline, saline load and recovery periods for the assessment of PRA. Within 2–3 days of experimentation, sheep were killed with an overdose of pentobarbitone sodium (100 mg/kg, iv.).
+ Open protocol
+ Expand
3

Basal Renal Function Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Basal renal function (time control experiment) was determined over a period of 3 hours during vehicle infusion (12 ml/h 0.9% isotonic saline, Baxter Healthcare, USA). A day prior to this, all animals had a catheter inserted into their right and left jugular vein (PE tubing, 1.2 × 1.0, Microtube Extrusions, Australia) for infusion purposes. On the morning of the experiment, a Foley catheter (Size 8 or 10, Uromedical, Australia) was inserted into the bladder for continuous urine collection. 51Chromium ethylenediaminetetraacetic acid (51Cr EDTA) and para-aminohippuric acid (PAH), was administered (i.v.) for the determination of glomerular filtration rate (GFR) and renal blood flow (RBF), respectively, via clearance methods as previously described55 (link). An equilibration period of one hour was allowed for the 51Cr EDTA and PAH to reach steady-state within the plasma. Following the equilibration period, urine samples were collected at 20 minute intervals, with an arterial blood sample (5 ml) collected mid-point, for a period of 3 hours. Blood pressure and heart rate were monitored continuously during this period.
+ Open protocol
+ Expand
4

Recombinant Human Erythropoietin Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human erythropoietin (EPOGEN® 2000 IU/mL, Amgen, Thousand Oaks, CA, United States) is a 165 amino acid glycoprotein produced by mammalian cells transfected with the human erythropoietin gene using the recombinant DNA technology. Other materials which were used in this study include isotonic saline (0.9% sodium chloride injection, Baxter, Deerfield, IL, United States), bovine serum albumin lyophilized powder (Sigma-Aldrich, St. Louis, MO, United States), EDTA (2%) (Sigma-Aldrich, St. Louis, MO, United States), isoflurane (Piramal Healthcare Limited, India), DPBS (Thermo Fisher Scientific, Waltham, MA, United States), RPMI Medium 1640 (Thermo Fisher Scientific, Waltham, MA, United States), biotin (Sigma-Aldrich, St. Louis, MO, United States), dimethyl sulfoxide (Themo Fisher Scientific, Waltham, MA, United States), R-phycoerythrin (Thermo Fisher Scientific, Waltham, MA, United States), and Retic-Count Reagent (BD Biosciences, San Jose, CA, United States).
+ Open protocol
+ Expand
5

Drug Preparation and Sourcing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Morphine sulfate was purchased from Mallinckrodt (St. Louis, MO) or provided by NIDA. Naloxone and naltrexone were purchased from Sigma-Aldrich (St. Louis, MO). All drugs and test compounds were dissolved in pyrogen-free isotonic saline (Baxter Healthcare, Deerfield, IL) or sterile-filtered distilled/deionized water. All radioligands were purchased from PerkinElmer, Boston, MA.
+ Open protocol
+ Expand
6

Radiolabeled Compound Formulation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stock solutions of the radiolabeled component were prepared in sterile water (Baxter, Deerfield, IL), prior to being added to the dose formulations, in appropriate quantities. Formulations were prepared by dissolving the appropriate amount of API and [ 14 C]-3,4,3-LI(1,2-HOPO) in isotonic saline (Baxter, Deerfield, IL) for mouse studies or Dulbecco's phosphate buffered saline (PBS, Sigma-Aldrich, Milwaukee, WI) for rat studies. In some instances, this was followed by the addition of a proprietary PE (purity: >97.0%; TCI America, Portland, OR). The solution was then adjusted with 1 M NaOH to a final pH of 7.0 for parenteral formulations, 7.4 for mouse po formulations, and 6.5 for rat po formulations; parenteral solutions were filter-sterilized (0.2 lm). The final stable API concentrations and corresponding specific activities were as follows: 13 mg/mL (17.5 lCi/mL) for mouse iv, ip, and po formulations; 15 mg/mL (40 lCi/mL) and 7.5 mg/mL (20 lCi/mL) for rat iv and po formulations, respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!